我们改变生活
推动体系变革
过去 5 年中，世界卫生组织新发布的指南中有三分之二引用了至少 1 篇Cochrane系统综述。了解我们的影响。
我们的证据
值得信赖
科学家、政策制定者和决策者向我们寻求可靠的证据。了解我们的证据为什么值得信赖。
我们在全球范围内
开展合作
我们通过与各领域专家和公众广泛合作，产出卓越的证据。加入我们。
News
What makes Cochrane’s new AI study innovative?
17 四月 2026
Cochrane has released a pre-print of the protocol for our innovative study that will test whether artificial intelligence (AI) tools can support or enhance evidence synthesis. Gerald Gartlehner from Cochrane Austria, Principal Investigator for the study, discusses how the study works, and what makes it interesting.
Anti-amyloid Alzheimer’s drugs show no clinically meaningful effect
16 四月 2026
Drugs that target amyloid beta proteins in the brain likely have no clinically meaningful positive effects, while increasing the risk of bleeding and swelling in the brain, a new Cochrane review has found.
Simple antiseptic can reduce newborn infections
26 三月 2026
A new Cochrane review finds that chlorhexidine likely cuts umbilical cord infection rates by about 29% in low- and middle- income countries, and may reduce newborn deaths.
Rupa Sarkar joins Cochrane as Editor in Chief
23 三月 2026
The Cochrane Collaboration is delighted to announce that Rupa Sarkar starts today as the new Editor in Chief.
是什么让Cochrane与众不同？
了解我们独特的健康相关证据、我们的工作方式以及我们所带来的改变。
需要定制的证据服务？
我们为任何使用健康证据的人提供工具、数据和定制服务。
撰写Cochrane系统综述？
需要撰写系统综述的指导？有兴趣成为Cochrane作者？
